View study details on clinicaltrials.gov.
Clinical Trial FAQs
Information for patients and study volunteers, including frequently asked questions.
The primary objective is to confirm the efficacy of intravaginal prasterone (DHEA) on Hypoactive Sexual Desire Disorder (HSDD) in postmenopausal women.
Please note that trial statuses change frequently. For the most up-to-date information, please contact the Research Department at 510.204.4155.
Lung Cancer in Never Smokers: Incidence, Risk Factors and Molecular Characteristics in Asian American, Native Hawaiian, and Pacific Islander (AANHPI) Women
Investigators: Su-Ying Liang, Ph.D., External PI, Principal Investigator
Using Electronic Health Records to Understand Pathways of Breast Cancer Screening and Care
Breast Tumor and Blood markers for Molecular Diagnosis of Breast Diseases and Monitoring of Breast Cancer Treatment and Follow-up
Latinas' Experiences of Breast Cancer Treatment in Santa Cruz County
Understanding the Experiences of Patients Undergoing Genetic Counseling and Testing for BRCA
Bay Area Breastfeeding Experience Survey (BABES)
Primary and Secondary Prevention of Osteoporosis-Related Fracture: The Use of DEXA and FRAX Results in a Community–based Practice
Measuring Real-World Breast Cancer Care
Improving Outcomes for Breast Cancer Patients: A PAMF-Stanford Research Collaboration
Investigator: Su-Ying Liang, Ph.D.